4/2/25 08:23 | 3/31/25 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Vos Ellen O'Connor | TX | D | | 2 | M.d | 0 | 0.00 | 0 | 11 | 18 | 69 | D | | | | | | | | | | | | | | |
4/1/25 21:01 | 12/31/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Parnell Winfred | TX | D | | 2 | M.d | 0 | 0.00 | 0 | 10 | 19 | 66 | D | | | | | | | | | | | | | | |
4/1/25 20:59 | 3/31/25 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Beausang Ellen | TX | D | | 1 | M.d | 0 | 0.00 | 0 | 2 | | 2 | D | | | | | | | | | | | | | | |
4/1/25 18:42 | 12/31/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cavanaugh Stefanie L. | TX | D | | 2 | M.d | 0 | 0.00 | 0 | 12 | 19 | 73 | D | | | | | | | | | | | | | | |
4/1/25 18:42 | 12/31/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ragard John Phillip | TX | D | | 2 | M.d | 0 | 0.00 | 0 | 10 | 8 | 130 | D | | | | | | | | | | | | | | |
4/1/25 18:42 | 12/31/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Herchuk Jannie Prestridge | TX | D | | 2 | M.d | 0 | 0.00 | 0 | 17 | 30 | 74 | D | | | | | | | | | | | | | | |
4/1/25 18:42 | 12/31/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Fralick Celeste Rachelle | TX | D | | 2 | M.d | 0 | 0.00 | 0 | 10 | 22 | 56 | D | | | | | | | | | | | | | | |
3/27/25 08:13 | 3/26/25 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | NV | DO | P,CEO | 1 | P | 100 | 0.5500 | 0 | 182 | 6 | 3,341 | D | | | | | | | | | | | | | | |
3/27/25 08:13 | 3/26/25 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D | | 1 | P | 100 | 0.5500 | 0 | 182 | 6 | 3,243 | D | | | | | | | | | | | | | | |
3/19/25 18:44 | 3/17/25 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Marshall Robert J. Jr. | MA | O | CFO,Trea | 1 | S | -1,005 | 100.52 | 0 | -10 | | 114 | D | | | | | | | | | | | | | | |
3/19/25 16:38 | 3/17/25 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Oki Mark K | WA | O | CFO | 1 | P | 29 | 2.89 | 0 | 10 | | 10 | D | | | | | | | | | | | | | | |
3/19/25 16:32 | 3/17/25 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Stewart Richard Alistair | WA | DO | Chieve E | 1 | P | 29 | 2.86 | 0 | 10 | 19 | 62 | D | | | | | | | | | | | | | | |
3/17/25 20:09 | 6/7/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | D | | 2 | S.m | -5,011 | 94.35 | 0 | -53 | | 608 | I | | | | | | | | | | | | | | |
3/7/25 17:44 | 3/5/25 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Blanchfield Paul | MA | O | P | 1 | S.d | -204 | 98.00 | 0 | -2 | | 119 | D | | | | | | | | | | | | | | |
3/4/25 16:43 | 3/4/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Clark Eliana | MA | O | EVP,Chie | 2 | S.dm | -103 | 11.92 | 0 | -9 | | 95 | D | | | | | | | | | | | | | | |
3/4/25 16:21 | 3/4/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Basta James | MA | O | EVP,GC | 2 | S.d | -109 | 11.33 | 0 | -10 | | 112 | D | | | | | | | | | | | | | | |
2/18/25 21:44 | 2/14/25 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO, | 1 | M.d | 0 | 0.00 | 0 | 1 | 2 | 50 | D | | | | | | | | | | | | | | |
2/18/25 21:43 | 2/14/25 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith Martin Alexander | ME | O | EVP | 1 | M.d | 0 | 0.00 | 0 | 1 | 765 | 1 | D | | | | | | | | | | | | | | |
2/18/25 21:43 | 2/14/25 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Schreck Michael | ME | O | EVP | 1 | M.d | 0 | 0.00 | 0 | 1 | 294 | 2 | D | | | | | | | | | | | | | | |
2/18/25 21:43 | 2/14/25 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | 1 | M.d | 0 | 0.00 | 0 | 3 | 3 | 83 | D | | | | | | | | | | | | | | |
2/18/25 21:43 | 2/14/25 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lane Michael | ME | O | EVP | 1 | M.d | 0 | 0.00 | 0 | 1 | 13 | 8 | D | | | | | | | | | | | | | | |
2/18/25 21:43 | 2/14/25 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Johnson Michael Perkins | ME | O | EVP | 1 | M.d | 0 | 0.00 | 0 | 0 | 317 | 0 | D | | | | | | | | | | | | | | |
2/18/25 21:43 | 2/14/25 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hunt Nimrata | ME | O | EVP | 1 | M.d | 0 | 0.00 | 0 | 1 | 8 | 12 | D | | | | | | | | | | | | | | |
2/18/25 21:42 | 2/14/25 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Fennell George | ME | O | EVP | 3 | M.dm | 5,513 | 256.04 | 0 | 22 | | 8 | D | | | | | | | | | | | | | | |
2/18/25 21:42 | 2/14/25 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Erickson Michael G | ME | O | EVP | 2 | M.d | 105 | 49.86 | 0 | 2 | 11 | 21 | D | | | | | | | | | | | | | | |
2/11/25 19:00 | 2/7/25 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | James Andrea S. | CA | O | CFO | 1 | P | 200 | 2.05 | 0 | 98 | 182 | 151 | D | | | | | | | | | | | | | | |
2/11/25 17:00 | 2/7/25 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith Patrick W | CA | T | | 4 | P.m | 2,253 | 2.05 | 0 | 1,099 | 51 | 3,258 | I | | | | | | | | | | | | | | |
2/10/25 20:43 | 2/6/25 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Broadwood Partners, L.P. | NY | T | | 1 | P.d | 10,590 | 2.05 | 0 | 5,166 | 29 | 22,820 | M | | | | | | | | | | | | | | |
2/3/25 19:26 | 1/31/25 | IONS | Ionis Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hougen Elizabeth L | CA | O | EVP,Fina | 3 | S.d | -340 | 9.93 | 0 | -34 | | 111 | D | | | | | | | | | | | | | | |
1/31/25 16:17 | 1/29/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bhanji Muna | MA | D | | 1 | S | -3 | 9.97 | 0 | 0 | | 19 | D | | | | | | | | | | | | | | |
1/29/25 17:20 | 12/31/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Milligan Sandra | TX | O | Interim | 2 | M.d | 0 | 0.00 | 0 | 40 | | 20 | D | | | | | | | | | | | | | | |
1/17/25 16:15 | 1/15/25 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Thrall James H | MA | D | | 1 | S | -95 | 94.76 | 0 | -1 | | 33 | D | | | | | | | | | | | | | | |
1/16/25 15:28 | 1/16/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Naemura David H. | MI | O | CFO | 1 | P | 164 | 11.11 | 0 | 15 | 32 | 61 | D | | | | | | | | | | | | | | |
1/16/25 12:05 | 1/16/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | MI | O | CEO | 1 | P | 254 | 11.03 | 0 | 23 | 9 | 269 | D | | | | | | | | | | | | | | |
1/7/25 17:23 | 1/3/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dube Michael P | MA | O | VP,Chief | 1 | S | -17 | 12.18 | 0 | -1 | | 46 | D | | | | | | | | | | | | | | |
1/7/25 17:20 | 1/3/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | 1 | S | -116 | 12.18 | 0 | -10 | | 88 | D | | | | | | | | | | | | | | |
1/7/25 17:20 | 1/3/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hicks Derek | MA | O | EVP,Chie | 1 | S | -79 | 12.18 | 0 | -7 | | 60 | D | | | | | | | | | | | | | | |
1/7/25 17:19 | 1/3/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | 1 | S | -327 | 12.18 | 0 | -27 | | 1,000 | D | | | | | | | | | | | | | | |
1/7/25 17:16 | 1/3/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sepp-Lorenzino Laura | MA | O | EVP,Chie | 1 | S | -109 | 12.18 | 0 | -9 | | 77 | D | | | | | | | | | | | | | | |